294 related articles for article (PubMed ID: 29606313)
1. Beyond Tissue Stiffness and Bioadhesivity: Advanced Biomaterials to Model Tumor Microenvironments and Drug Resistance.
Singh A; Brito I; Lammerding J
Trends Cancer; 2018 Apr; 4(4):281-291. PubMed ID: 29606313
[TBL] [Abstract][Full Text] [Related]
2. Why Tumor Genetic Heterogeneity May Require Rethinking Cancer Genesis and Treatment.
Gottlieb B; Trifiro M; Batist G
Trends Cancer; 2021 May; 7(5):400-409. PubMed ID: 33243702
[TBL] [Abstract][Full Text] [Related]
3. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Shapira A; Livney YD; Broxterman HJ; Assaraf YG
Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
[TBL] [Abstract][Full Text] [Related]
4. Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach.
Taylor S; Spugnini EP; Assaraf YG; Azzarito T; Rauch C; Fais S
Drug Resist Updat; 2015 Nov; 23():69-78. PubMed ID: 26341193
[TBL] [Abstract][Full Text] [Related]
5. Harnessing the power of human tumor-derived cell lines for the rational design of cancer therapies.
Plaisier CL; Baliga NS
Pigment Cell Melanoma Res; 2012 Jul; 25(4):406-8. PubMed ID: 22781216
[No Abstract] [Full Text] [Related]
6. Addressing intra-tumoral heterogeneity and therapy resistance.
Rybinski B; Yun K
Oncotarget; 2016 Nov; 7(44):72322-72342. PubMed ID: 27608848
[TBL] [Abstract][Full Text] [Related]
7. Reengineering the Physical Microenvironment of Tumors to Improve Drug Delivery and Efficacy: From Mathematical Modeling to Bench to Bedside.
Stylianopoulos T; Munn LL; Jain RK
Trends Cancer; 2018 Apr; 4(4):292-319. PubMed ID: 29606314
[TBL] [Abstract][Full Text] [Related]
8. Cancer cell metabolism: Rewiring the mitochondrial hub.
Oliveira GL; Coelho AR; Marques R; Oliveira PJ
Biochim Biophys Acta Mol Basis Dis; 2021 Feb; 1867(2):166016. PubMed ID: 33246010
[TBL] [Abstract][Full Text] [Related]
9. Exosomes and their role in tumorigenesis and anticancer drug resistance.
Milman N; Ginini L; Gil Z
Drug Resist Updat; 2019 Jul; 45():1-12. PubMed ID: 31369918
[TBL] [Abstract][Full Text] [Related]
10. Cancer drug resistance: A fleet to conquer.
Hussain S; Singh A; Nazir SU; Tulsyan S; Khan A; Kumar R; Bashir N; Tanwar P; Mehrotra R
J Cell Biochem; 2019 Sep; 120(9):14213-14225. PubMed ID: 31037763
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiologically relevant in vitro tumor models for drug screening.
Das V; Bruzzese F; Konečný P; Iannelli F; Budillon A; Hajdúch M
Drug Discov Today; 2015 Jul; 20(7):848-55. PubMed ID: 25908576
[TBL] [Abstract][Full Text] [Related]
12. The tumor microenvironment is a dominant force in multidrug resistance.
Correia AL; Bissell MJ
Drug Resist Updat; 2012; 15(1-2):39-49. PubMed ID: 22335920
[TBL] [Abstract][Full Text] [Related]
13. The emerging roles of exosomes in anti-cancer drug resistance and tumor progression: An insight towards tumor-microenvironment interaction.
Jena BC; Mandal M
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188488. PubMed ID: 33271308
[TBL] [Abstract][Full Text] [Related]
14. In vitro biomimetic models for glioblastoma-a promising tool for drug response studies.
Stanković T; Ranđelović T; Dragoj M; Stojković Burić S; Fernández L; Ochoa I; Pérez-García VM; Pešić M
Drug Resist Updat; 2021 Mar; 55():100753. PubMed ID: 33667959
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal Cell Plasticity and Perfidy in Epithelial Malignancy.
Puré E; Hingorani SR
Trends Cancer; 2018 Apr; 4(4):273-277. PubMed ID: 29606311
[TBL] [Abstract][Full Text] [Related]
16. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
Dzobo K
OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
[TBL] [Abstract][Full Text] [Related]
17. Interventions that induce modifications in the tumor microenvironment.
Bernhard EJ
Cancer Radiother; 2011 Aug; 15(5):376-82. PubMed ID: 21571567
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory Function of the Tumor Suppressor p53 in Host Immune Response and the Tumor Microenvironment.
Cui Y; Guo G
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869779
[TBL] [Abstract][Full Text] [Related]
19. Heparanase: From basic research to therapeutic applications in cancer and inflammation.
Vlodavsky I; Singh P; Boyango I; Gutter-Kapon L; Elkin M; Sanderson RD; Ilan N
Drug Resist Updat; 2016 Nov; 29():54-75. PubMed ID: 27912844
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of cancer-associated fibroblasts: Opportunities for precision medicine.
Kanzaki R; Pietras K
Cancer Sci; 2020 Aug; 111(8):2708-2717. PubMed ID: 32573845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
